BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fung BM, Lindor KD, Tabibian JH. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies. World J Gastroenterol 2019; 25(6): 659-671 [PMID: 30783370 DOI: 10.3748/wjg.v25.i6.659]
URL: https://www.wjgnet.com/1007-9327/full/v25/i6/659.htm
Number Citing Articles
1
Teresa Brevini, Olivia C. Tysoe, Fotios Sampaziotis. Tissue engineering of the biliary tract and modelling of cholestatic disordersJournal of Hepatology 2020; 73(4): 918 doi: 10.1016/j.jhep.2020.05.049
2
Brian M. Fung, James H. Tabibian. Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practicesExpert Review of Gastroenterology & Hepatology 2021; 15(5): 487 doi: 10.1080/17474124.2021.1900732
3
Alexander Strick, Hans Busch, Klaus Friedhoff. Gallenblasenmetastase eines malignen MelanomsDMW - Deutsche Medizinische Wochenschrift 2022; 147(19): 1277 doi: 10.1055/a-1918-5473
4
Natassia Tan, Natalie Ngu, Thomas Worland, Tanya Lee, Tobie Abrahams, Elliot Freeman, Nicholas Hannah, Kathryn Gazelakis, Richie G Madden, Kate D Lynch, Zina Valaydon, Siddharth Sood, Anouk Dev, Sally Bell, Alexander J Thompson, John Nik Ding, Amanda J Nicoll, Ken Liu, Keval Pandya, Paul Gow, John Lubel, William Kemp, Stuart K Roberts, Ammar Majeed. Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitisHepatology Communications 2024; 8(5) doi: 10.1097/HC9.0000000000000442
5
Martina Taborelli, Michele Sozzi, Stefania Del Zotto, Federica Toffolutti, Marcella Montico, Loris Zanier, Diego Serraino, Jeffrey S. Chang. Risk of intestinal and extra-intestinal cancers in patients with inflammatory bowel diseases: A population-based cohort study in northeastern ItalyPLOS ONE 2020; 15(6): e0235142 doi: 10.1371/journal.pone.0235142
6
Lu Jiang, Peter Stärkel, Jian-Gao Fan, Derrick Eugene Fouts, Petra Bacher, Bernd Schnabl. The gut mycobiome: a novel player in chronic liver diseasesJournal of Gastroenterology 2021; 56(1): 1 doi: 10.1007/s00535-020-01740-5
7
Domenico Alvaro, Cesare Hassan, Vincenzo Cardinale, Guido Carpino, Luca Fabris, Enrico Gringeri, Vincenza Granata, Massimiliano Mutignani, Helen Morement, Felice Giuliante, Alfredo Guglielmi, Lorenzo Ridola, Marco Marzioni, Gianluca Grazi, Maria Guido, Emilio Di Giulio, Giuseppe Tonini, Francesco Pantano, Rosanna Venere, Maria Consiglia Bragazzi, Francesca Biancanello, Jessica Faccioli, Aurora Giannetti, Marcello Cintolo, Michela Di Giunta, Martina Gambato, Alberto Lasagni, Francesco Izzo, Antonio Avallone, Jesus Banales, Massimo Rossi, Carlo Catalano, Andrea Laghi, Giulia D'amati, Maria Grazia Mancino, Lorenzo Ridola. Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and stagingDigestive and Liver Disease 2020; 52(11): 1282 doi: 10.1016/j.dld.2020.06.045
8
Sarah Kemme, Cara L. Mack. Pediatric Autoimmune Liver DiseasesPediatric Clinics of North America 2021; 68(6): 1293 doi: 10.1016/j.pcl.2021.07.006
9
Sohini Das, Manoj Job, Thomas Kodiatte, Ramya Iyadurai. Atypical presentation of intrahepatic cholangiocarcinoma---Fever and ascites in a postpartum ladyJournal of Family Medicine and Primary Care 2019; 8(11): 3748 doi: 10.4103/jfmpc.jfmpc_748_19
10
Johanna Eliasson, Bobby Lo, Christoph Schramm, Olivier Chazouilleres, Trine Folseraas, Ulrich Beuers, Henriette Ytting. Survey uncovering variations in the management of primary sclerosing cholangitis across EuropeJHEP Reports 2022; 4(11): 100553 doi: 10.1016/j.jhepr.2022.100553
11
Michael Bitzer, Sabrina Groß, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0Zeitschrift für Gastroenterologie 2024; 62(01): e67 doi: 10.1055/a-2189-6353
12
Dominic Staudenmann, Mark Bonnichsen, Payal Saxena, Arthur John Kaffes. Endoscopic Evaluation of Indeterminate Biliary Strictures: a ReviewCurrent Treatment Options in Gastroenterology 2021; 19(2): 308 doi: 10.1007/s11938-021-00339-w
13
Alireza Beheshti-Maal, Atena Tamimi, Shahrokh Iravani, Arash Memarnejadian, Majid Sorouri, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali, Nikoo Hossein Khannazer, Massoud Vosough. PSC associated inflammatory bowel disease: a distinct entityExpert Review of Gastroenterology & Hepatology 2022; 16(2): 129 doi: 10.1080/17474124.2022.2031979
14
D. Bel Haj Yahia, M. Bel Hadj Yahya, I. Chelly, R. Ksantini, M. Jouini, M.J. Kacem. 21 years of evolution of primary hepatic neuroendocrine neoplasm in a patient with primary sclerosing cholangitis: A case reportInternational Journal of Surgery Case Reports 2023; 106: 108205 doi: 10.1016/j.ijscr.2023.108205
15
David M. Chascsa, Keith D. Lindor. Cancer risk, screening and surveillance in primary sclerosing cholangitisMinerva Gastroenterologica e Dietologica 2019; 65(3) doi: 10.23736/S1121-421X.19.02586-8
16
Rodrigo V Motta, Vipin Gupta, Karen Hartery, Paul Bassett, Simon J Leedham, Roger W Chapman, Simon PL Travis, Emma L Culver, James E. East. Dye-based chromoendoscopy detects more neoplasia than white light endoscopy in patients with primary sclerosing cholangitis and IBDEndoscopy International Open 2024; 12(11): E1285 doi: 10.1055/a-2437-8102
17
Brian M. Fung, James H. Tabibian. Cholangiocarcinoma in patients with primary sclerosing cholangitisCurrent Opinion in Gastroenterology 2020; 36(2): 77 doi: 10.1097/MOG.0000000000000616
18
Mohammad Mawardi, Abduljaleel Alalwan, Hind Fallatah, Faisal Abaalkhail, Mohammed Hasosah, Mohammad Shagrani, Mohammed Y Alghamdi, Abdullah S Alghamdi. Cholestatic liver diseaseSaudi Journal of Gastroenterology 2021; 27(Suppl 1): S1 doi: 10.4103/sjg.sjg_112_21
19
Atit Silsirivanit, Chatchai Phoomak, Sopit Wongkham. Diagnosis and Management of Cholangiocarcinoma2021; : 527 doi: 10.1007/978-3-030-70936-5_25
20
S. Franssen, D. M. de Jong, L. M. J. W. van Driel, B. Groot Koerkamp. Diagnosis and Management of Cholangiocarcinoma2021; : 229 doi: 10.1007/978-3-030-70936-5_9
21
Mario Altieri, Olivier Sérée, Thierry Lobbedez, Philippe Segol, Armand Abergel, Xavier Blaizot, Olivier Boillot, Karim Boudjema, Audrey Coilly, Filomena Conti, Olivier Chazouillères, Maryline Debette-Gratien, Sébastien Dharancy, François Durand, Christophe Duvoux, Claire Francoz, Jean Gugenheim, Jean Hardwigsen, Pauline Houssel-Debry, Nassim Kamar, Marianne Latournerie, Pascal Lebray, Vincent Leroy, Martine Neau-Cransac, Georges-Philippe Pageaux, Sylvie Radenne, Ephrem Salamé, Faouzi Saliba, Didier Samuel, Claire Vanlemmens, Camille Besch, Guy Launoy, Jérôme Dumortier. Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patientsClinics and Research in Hepatology and Gastroenterology 2021; 45(4): 101514 doi: 10.1016/j.clinre.2020.07.019
22
Francesca Saffioti, Vasileios K Mavroeidis. Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitisWorld Journal of Gastrointestinal Oncology 2021; 13(10): 1336-1366 doi: 10.4251/wjgo.v13.i10.1336
23
Nelli Sjöblom, Sonja Boyd, Hannu Kautiainen, Johanna Arola, Martti Färkkilä. Novel histological scoring for predicting disease outcome in primary sclerosing cholangitisHistopathology 2022; 81(2): 192 doi: 10.1111/his.14677
24
Anita Nguyen, Babak Torabi Sagvand, Madeline Alizadeh, Cydney Nguyen, William Scott, Erik C. von Rosenvinge. Primary sclerosing cholangitis and pancreatic cancer: A retrospective cohort study of United States veteransFrontiers in Gastroenterology 2023; 1 doi: 10.3389/fgstr.2022.1076788
25
Dong He, Wen Zeng, Yi Wang, Yifan Xing, Kang Xiong, Nan Su, Chong Zhang, Yuan Lu, Xinhui Xing. Isolation and characterization of novel peptides from fermented products of Lactobacillus for ulcerative colitis prevention and treatmentFood Science and Human Wellness 2022; 11(6): 1464 doi: 10.1016/j.fshw.2022.06.003
26
Marlone Cunha-Silva, Eloy Vianey Carvalho de França, Clauber Teles Veiga, Raquel Dias Greca, Priscilla Brito Sena de Moraes, Daniel Ferraz de Campos Mazo, Elaine Cristina de Ataíde, Simone Reges Perales, Leonardo Trevizan Monici, Tiago Sevá-Pereira. 15-Year progression to liver cancer in the lack of treatment for lysosomal acid lipase deficiency: A case reportMedicine 2022; 101(35): e30315 doi: 10.1097/MD.0000000000030315
27
Kazuma Daiku, Kazuto Fukuda, Osakuni Morimoto, Daisuke Takiuchi, Hiromi Shimakoshi, Tadashi Kegasawa, Yoshitaka Yamaguchi, Sachiyo Kogita, Yoshiyuki Sawai, Masanori Nakahara, Takumi Igura, Kunitaka Shibata, Yasuharu Imai. Primary adenosquamous carcinoma of the liver detected during cancer surveillance in a patient with primary sclerosing cholangitisClinical Journal of Gastroenterology 2020; 13(6): 1273 doi: 10.1007/s12328-020-01204-6
28
Dustin E. Bosch, Yoh Zen, Sarag A. Boukhar, Yongjun Liu, Lin Cheng, Matthew M. Yeh. Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging settingVirchows Archiv 2021; 479(6): 1131 doi: 10.1007/s00428-021-03183-6
29
Rohit Das, Harkirat Singh, Adam Slivka. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy2020; : 1 doi: 10.1007/978-3-030-29964-4_80-1
30
Chaofu Li, Yating Deng, Yating Pan, Xinyi Liao, Huadong Xie, Xiaoli Xue, Shaoqing Yu, Wenlong Yu, Guanzhen Yu. Metformin dampens the progression of cholangiofibrosis induced by thioacetamide using deep learningHeliyon 2024; 10(18): e37347 doi: 10.1016/j.heliyon.2024.e37347
31
Islam B. Mohamed, Ahmed El Sabagh, Fuad ZainAloor, Mohamed El Talkhan, Zahraa Al lami, Megha Bhongade, Shilpa Jain, Prasun K. Jalal. Hepatology2025; : 1181 doi: 10.1016/B978-0-443-26711-6.00041-X
32
Lei Huang. 2020 International Conference on Applications and Techniques in Cyber IntelligenceAdvances in Intelligent Systems and Computing 2021; 1244: 180 doi: 10.1007/978-3-030-53980-1_27
33
Rohit Das, Harkirat Singh, Adam Slivka. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy2022; : 1381 doi: 10.1007/978-3-030-56993-8_80
34
Erik Lundqvist, Ida Hed Myrberg, Sol Erika Boman, Deborah Saraste, Caroline E. Weibull, Kalle Landerholm, Staffan Haapaniemi, Anna Martling, Pär Myrelid, Caroline Nordenvall. Autoimmune and Metabolic Diseases and the Risk of Early-Onset Colorectal Cancer, a Nationwide Nested Case–Control StudyCancers 2023; 15(3): 688 doi: 10.3390/cancers15030688
35
Haonan Zhang, Yulu Shi, Chanchan Lin, Chengcheng He, Shanping Wang, Qingyuan Li, Yan Sun, Mingsong Li. Overcoming cancer risk in inflammatory bowel disease: new insights into preventive strategies and pathogenesis mechanisms including interactions of immune cells, cancer signaling pathways, and gut microbiotaFrontiers in Immunology 2024; 14 doi: 10.3389/fimmu.2023.1338918
36
Juan E. Corral, Kristopher P. Croome, Andrew P. Keaveny, Bhaumik Brahmbhatt, Paul T. Kröner, Karn Wijarnpreecha, Rohan M. Goswami, Massimo Raimondo, Michael B. Wallace, Yan Bi, Omar Y. Mousa. A 3-Decade Analysis of Pancreatic Adenocarcinoma After Solid Organ TransplantPancreas 2021; 50(1): 54 doi: 10.1097/MPA.0000000000001722
37
Silja Steinmann, Ida Schregel, Christoph Schramm. Autoimmune Lebererkrankungen – ein Update (Teil 1)Gastroenterologie up2date 2022; 18(03): 225 doi: 10.1055/a-1364-8489
38
Ahmad Hassan Ali, Elizabeth J. Carey. Diagnosis and Management of Cholangiocarcinoma2021; : 435 doi: 10.1007/978-3-030-70936-5_20
39
Brigida Barberio, Davide Massimi, Nora Cazzagon, Fabiana Zingone, Alexander C. Ford, Edoardo V. Savarino. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysisGastroenterology 2021; 161(6): 1865 doi: 10.1053/j.gastro.2021.08.032
40
Katy L. Lawson, Hanlin L. Wang. Primary Sclerosing Cholangitis, Small Duct Primary Sclerosing Cholangitis, IgG4-Related Sclerosing Cholangitis, and Ischemic CholangiopathySurgical Pathology Clinics 2023; 16(3): 533 doi: 10.1016/j.path.2023.04.008
41
Stanisław Rządkowski, Agnieszka Chmielińska, Marek Pacholczyk, Beata Łągiewska. Colonoscopy Surveillance in Liver Transplant Recipients for Primary Sclerosing Cholangitis Associated With Inflammatory Bowel DiseaseTransplantation Proceedings 2020; 52(8): 2484 doi: 10.1016/j.transproceed.2020.01.116
42
M. Bitzer, S. Voesch, J. Albert, P. Bartenstein, W. Bechstein, S. Blödt, T. Brunner, F. Dombrowski, M. Evert, M. Follmann, C. La Fougère, P. Freudenberger, A. Geier, E. Gkika, M. Götz, E. Hammes, T. Helmberger, R. T. Hoffmann, W. P. Hofmann, P. Huppert, A. Kautz, G. Knötgen, J. Körber, D. Krug, F. Lammert, H. Lang, T. Langer, P. Lenz, A. Mahnken, A. Meining, O. Micke, S. Nadalin, H. P. Nguyen, J. Ockenga, K. Oldhafer, P. Paprottka, K. Paradies, P. Pereira, T. Persigehl, M. Plauth, R. Plentz, J. Pohl, J. Riemer, P. Reimer, J. Ringwald, U. Ritterbusch, E. Roeb, B. Schellhaas, P. Schirmacher, I. Schmid, A. Schuler, D. von Schweinitz, D. Seehofer, M. Sinn, A. Stein, A. Stengel, N. Steubesand, C. Stoll, A. Tannapfel, A. Taubert, J. Trojan, I. van Thiel, R. Tholen, A. Vogel, T. Vogl, H. Vorwerk, F. Wacker, O. Waidmann, H. Wedemeyer, H. Wege, D. Wildner, C. Wittekind, M. A. Wörns, P. Galle, N. Malek. S3-Leitlinie – Diagnostik und Therapie biliärer KarzinomeZeitschrift für Gastroenterologie 2022; 60(02): e186 doi: 10.1055/a-1589-7854
43
Agnes Wittek, Babett Steglich, Christian Casar, Oliver Seiz, Philipp Huber, Hanno Ehlken, Dominik Reher, Sandra Wende, Tanja Bedke, Jan Kempski, Marius Böttcher, Corinna Bang, Louise Thingholm, Till Krech, Ansgar W Lohse, Guido Sauter, Thomas Rösch, Andre Franke, Christoph Schramm, Nicola Gagliani, Penelope Pelczar, Samuel Huber. A Gradient of Intestinal Inflammation in Primary Sclerosing CholangitisInflammatory Bowel Diseases 2024; 30(6): 900 doi: 10.1093/ibd/izad137
44
Fiona Hand, Emir Hoti. Contemporary role of liver transplantation for the treatment of cholangiocarcinomaExpert Review of Gastroenterology & Hepatology 2020; 14(6): 475 doi: 10.1080/17474124.2020.1765771
45
Patrick F. van Rheenen. Managing abnormal liver tests in children with inflammatory bowel diseaseCurrent Opinion in Pediatrics 2021; 33(5): 521 doi: 10.1097/MOP.0000000000001045
46
Pavel Wohl, Alzbeta Krausova, Petr Wohl, Ondrej Fabian, Lukas Bajer, Jan Brezina, Pavel Drastich, Mojmir Hlavaty, Petra Novotna, Michal Kahle, Julius Spicak, Martin Gregor. Limited validity of Mayo endoscopic subscore in ulcerative colitis with concomitant primary sclerosing cholangitisWorld Journal of Gastrointestinal Endoscopy 2024; 16(11): 607-616 doi: 10.4253/wjge.v16.i11.607
47
Vitantonio GUGLIELMI, Pietro GIORGIO, Vito GUERRA, Anna SONNANTE, Massimo TUTINO, Rossella DONGHIA, Antonio PISANI. Prognostic value of perinuclear antineutrophil cytoplasmic antibodies in subjects with primary sclerosing cholangitisMinerva Medica 2022; 113(3) doi: 10.23736/S0026-4806.20.06604-5
48
Fouad Jaber, George Cholankeril, Hashem B El-Serag. Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategiesJournal of the Canadian Association of Gastroenterology 2024; 7(5): 331 doi: 10.1093/jcag/gwae025
49
Morten D. Jensen, Peter Jepsen, Hendrik Vilstrup, Lisbet Grønbæk. Increased Cancer Risk in Autoimmune Hepatitis: A Danish Nationwide Cohort StudyAmerican Journal of Gastroenterology 2022; 117(1): 129 doi: 10.14309/ajg.0000000000001525
50
Hoon Jai Chun, Seun Ja Park, Yun Jeong Lim, Si Young Song. Gastrointestinal Cancer2023; : 393 doi: 10.1007/978-981-99-0815-8_55
51
Gabriel Mosquera-Klinger, Nathalie Yepes Madrid, Jhon Jaime Carvajal Gutiérrez. Enfermedad de Crohn con compromiso extenso y manifestaciones extradigestivas inusuales: a propósito de un caso Revista colombiana de Gastroenterología 2021; 36(Supl. 1): 85 doi: 10.22516/25007440.605
52
Gautham Appanna, Yiannis Kallis. An update on the management of cholestatic liver diseasesClinical Medicine 2020; 20(5): 513 doi: 10.7861/clinmed.2020-0697
53
Taranika Sarkar Das, Kimberly Ho, Jahnavi Udaikumar, Bryan Chen, Olivia Delau, Aasma Shaukat, Ira Jacobson, Raiya Sarwar. Risk of colorectal cancer in patients with primary sclerosing cholangitis and concomitant inflammatory bowel disease compared with primary sclerosing cholangitis onlyHepatology Research 2024; 54(9): 807 doi: 10.1111/hepr.14029
54
Karoly Viragh, Maitraya Patel, Shaden Mohammad, Monica Deshmukh, Anokh Pahwa. Diagnosis and Management of Cholangiocarcinoma2021; : 179 doi: 10.1007/978-3-030-70936-5_7
55
Zhen-Jiao Li, Hong-Zhong Gou, Yu-Lin Zhang, Xiao-Jing Song, Lei Zhang. Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic valueWorld Journal of Gastroenterology 2022; 28(44): 6213-6229 doi: 10.3748/wjg.v28.i44.6213
56
Alexander Ney, Daniel C. Osei‐Bordom, Andres Garcia‐Sampedro, Pilar Acedo, Giuseppe K. Fusai, Martyn Stott, Phillip Hopley, Chandni Patel, Lucy Oldfield, William Greenhalf, Eithne Costello, Stephen P. Pereira. Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e2024; : 291 doi: 10.1002/9781119756422.ch17
57
Michael Trauner, Chuhan Chung, Kate Sterling, Xiangyu Liu, Xiaomin Lu, Jun Xu, Clare Tempany-Afdhal, Zachary D. Goodman, Martti Färkkilä, Atsushi Tanaka, Palak Trivedi, Kris V. Kowdley, Christopher L. Bowlus, Cynthia Levy, Robert P. Myers. PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitisBMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02653-2
58
Alexander Strick, Hans Busch, Klaus Friedhoff. Gallenblasenmetastase eines malignen MelanomsTumorDiagnostik & Therapie 2024; 45(01): 40 doi: 10.1055/a-2238-5283
59
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Athanasios G Papavassiliou, Michalis V Karamouzis. Role of autophagy in cholangiocarcinoma: An autophagy-based treatment strategyWorld Journal of Gastrointestinal Oncology 2021; 13(10): 1229-1243 doi: 10.4251/wjgo.v13.i10.1229
60
Hanlai Zhang, Yonghong Gao, Liqin Wang, Li Tian, Na An, Xinyu Yang, Xinye Li, Chao Tian, Mengchen Yuan, Xingjiang Xiong, Nian Liu, Hongcai Shang, Yanwei Xing. Does heart failure increase the risk of incident cancer? A meta-analysis and systematic reviewHeart Failure Reviews 2020; 25(6): 949 doi: 10.1007/s10741-019-09876-0
61
Richard Kellermayer, Marco Carbone, Thomas D. Horvath, Reka G. Szigeti, Cynthia Buness, Gideon M. Hirschfield, Peter J. Lewindon. Identifying a therapeutic window of opportunity for people living with primary sclerosing cholangitis: Embryology and the overlap of inflammatory bowel disease with immune-mediated liver injuryHepatology 2024;  doi: 10.1097/HEP.0000000000000926
62
Xiaohui Wang, Ting Fu, Junqiao Wang, Changyuan Wang, Kexin Liu, Jingjing Wu, Huijun Sun, Xiaodong Ma, Pengyuan Sun, Qiang Meng. Hepatoprotection of yangonin against hepatic fibrosis in mice via farnesoid X receptor activationInternational Immunopharmacology 2019; 75: 105833 doi: 10.1016/j.intimp.2019.105833
63
Ayesha Shah, Graeme A. Macdonald, Mark Morrison, Gerald Holtmann. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional FrameworkAmerican Journal of Gastroenterology 2020; 115(6): 814 doi: 10.14309/ajg.0000000000000604
64
Sara Momtazmanesh, Mehran Gholami, Neda Pak, Ali Reza Sima, Seyed Ali Montazeri, Shadi Kolahdoozan, Homayoun Vahedi, Amir Reza Radmard. The clinical significance of biliary findings in magnetic resonance enterography of patients with inflammatory bowel diseasePolish Journal of Radiology 2022; 87: 613 doi: 10.5114/pjr.2022.121443
65
Taylor D. Ellington, Behnoosh Momin, Reda J. Wilson, S. Jane Henley, Manxia Wu, A. Blythe Ryerson. Incidence and Mortality of Cancers of the Biliary Tract, Gallbladder, and Liver by Sex, Age, Race/Ethnicity, and Stage at Diagnosis: United States, 2013 to 2017Cancer Epidemiology, Biomarkers & Prevention 2021; 30(9): 1607 doi: 10.1158/1055-9965.EPI-21-0265
66
Florian Rennebaum, Claudia Demmig, Hartmut H. Schmidt, Richard Vollenberg, Phil-Robin Tepasse, Jonel Trebicka, Wenyi Gu, Hansjoerg Ullerich, Iyad Kabar, Friederike Cordes. Elevated Liver Fibrosis Progression in Isolated PSC Patients and Increased Malignancy Risk in a PSC-IBD Cohort: A Retrospective StudyInternational Journal of Molecular Sciences 2023; 24(20): 15431 doi: 10.3390/ijms242015431
67
Sabrina Groß, Michael Bitzer, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans J. Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0Zeitschrift für Gastroenterologie 2024; 62(02): e213 doi: 10.1055/a-2189-8567
68
A.V. Nikitin, G.V. Volynets, T.A. Skvortsova, M.S. Kapranova. Extraintestinal manifestations of inflammatory bowel diseaseDokazatel'naya gastroenterologiya 2023; 12(1): 93 doi: 10.17116/dokgastro20231201193
69
Ron Pery, Rory L Smoot, Cornelius A Thiels, Sean P Cleary, Robert A Vierkant, Sumera I Ilyas, Gregory J Gores, David M Nagorney. Hepatobiliary and pancreatic resection for cholangiocarcinoma in patients with primary sclerosing cholangitisBritish Journal of Surgery 2022; 109(11): 1032 doi: 10.1093/bjs/znac229
70
Rebecca Little, Eytan Wine, Binita M Kamath, Anne M Griffiths, Amanda Ricciuto. Gut microbiome in primary sclerosing cholangitis: A reviewWorld Journal of Gastroenterology 2020; 26(21): 2768-2780 doi: 10.3748/wjg.v26.i21.2768
71
Alphonse E. Sirica, Mario Strazzabosco, Massimiliano Cadamuro. Mechanisms and Therapy of Liver CancerAdvances in Cancer Research 2021; 149: 321 doi: 10.1016/bs.acr.2020.10.005
72
Silvia Cagnin, James H. Tabibian, Luca Fabris. Diagnosis and Management of Cholangiocarcinoma2021; : 251 doi: 10.1007/978-3-030-70936-5_10
73
Roongruedee Chaiteerakij. Diagnosis and Management of Cholangiocarcinoma2021; : 137 doi: 10.1007/978-3-030-70936-5_5
74
Zuzanna Lukasik, Dirk Elewaut, Koen Venken. MAIT Cells Come to the Rescue in Cancer Immunotherapy?Cancers 2020; 12(2): 413 doi: 10.3390/cancers12020413
75
Itzel Medina-Andrade, Jonadab E. Olguín, Tonathiu Rodríguez, Luis I. Terrazas. Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives2021; : 103 doi: 10.1016/B978-0-12-822028-3.00003-0
76
Sarah Poetter-Lang, Alina Messner, Nina Bastati, Kristina I. Ringe, Maxime Ronot, Sudhakar K. Venkatesh, Raphael Ambros, Antonia Kristic, Aida Korajac, Gregor Dovjak, Martin Zalaudek, Jacqueline. C. Hodge, Christoph Schramm, Emina Halilbasic, Michael Trauner, Ahmed Ba-Ssalamah. Diagnosis of functional strictures in patients with primary sclerosing cholangitis using hepatobiliary contrast-enhanced MRI: a proof-of-concept studyEuropean Radiology 2023; 33(12): 9022 doi: 10.1007/s00330-023-09915-3
77
Vinay K. Kapoor. A Pictorial Treatise on Gall Bladder Cancer2021; : 35 doi: 10.1007/978-981-15-5289-2_4
78
Viviana Laredo, Sandra García-Mateo, Samuel J. Martínez-Domínguez, Julia López de la Cruz, Carla J. Gargallo-Puyuelo, Fernando Gomollón. Risk of Cancer in Patients with Inflammatory Bowel Diseases and Keys for Patient ManagementCancers 2023; 15(3): 871 doi: 10.3390/cancers15030871
79
Michael Bitzer, Sabrina Groß, Jörg Albert, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, Achim Kautz, David Krug, Christian La Fougère, Hauke Lang, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – LangversionZeitschrift für Gastroenterologie 2023; 61(04): e92 doi: 10.1055/a-2026-1240
80
Giacomo C. Waller, Umut Sarpel. Gallbladder CancerSurgical Clinics of North America 2024; 104(6): 1263 doi: 10.1016/j.suc.2024.03.006